Atlas Trials

Clinical Study of mRNA Vaccine in Patients With Liver Cancer After Operation

Clinical trial NCT05761717 · UNKNOWN

Trial details

NCT number
NCT05761717
Sponsor
Shanghai Zhongshan Hospital
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Posto Perative Hepatocellular Carcinoma
Start date
2023-04-20
Primary completion
2025-03-12
Enrollment
67

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.